VYNE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $43,800.00

Insider Selling (Last 12 Months): $0.00

VYNE Therapeutics Insider Trading History Chart

VYNE Therapeutics Share Price & Price History

^$1.85

▼ -0.005 (-0.27%)

As of 03/13/2025 01:57 PM ET

Days: 30 | 90 | 365

VYNE Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/15/2025	Patrick G LePore	Director	Buy	15,000	$2.92	$43,800.00	51,472
11/15/2023	Patrick G LePore	Director	Buy	13,000	$3.91	$50,830.00	36,472
3/20/2023	Mutya Harsch	Insider	Buy	10,000	$2.50	$25,000.00	22,721
3/20/2023	Patrick G LePore	Director	Buy	20,000	$2.48	$49,600.00	23,472

SEC Filings (Institutional Ownership Changes) for VYNE Therapeutics (NASDAQ:VYNE)

83.78% of VYNE Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

VYNE Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Parkman Healthcare Partners LLC	152,973	$0.51M	0.1%	-24.6%	1.037%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	245,800	$0.82M	0.1%	N/A	1.666%
2/17/2025	Bridgeway Capital Management LLC	36,958	$0.12M	0.0%	N/A	0.251%
2/17/2025	Acorn Capital Advisors LLC	456,970	$1.53M	0.8%	N/A	3.098%
2/14/2025	Jane Street Group LLC	20,286	$68K	0.0%	N/A	0.138%
2/14/2025	Schonfeld Strategic Advisors LLC	176,658	$0.59M	0.0%	+4.8%	1.198%
2/14/2025	Northern Trust Corp	23,971	$80K	0.0%	-35.7%	0.163%
2/14/2025	Adage Capital Partners GP L.L.C.	154,134	$0.52M	0.0%	N/A	1.045%
2/13/2025	XTX Topco Ltd	21,018	$70K	0.0%	N/A	0.142%
2/13/2025	Renaissance Technologies LLC	24,943	$84K	0.0%	-71.2%	0.169%
11/15/2024	Parkman Healthcare Partners LLC	202,973	$0.38M	0.0%	-41.2%	1.376%
10/30/2024	AlphaCentric Advisors LLC	268,485	$0.51M	0.4%	-13.5%	1.820%
8/15/2024	Lynx1 Capital Management LP	16,194	$32K	0.0%	N/A	0.111%
8/9/2024	Renaissance Technologies LLC	63,111	$0.12M	0.0%	-21.7%	0.434%
7/26/2024	AlphaCentric Advisors LLC	310,500	$0.61M	0.5%	-30.2%	2.137%
5/20/2024	Virtu Financial LLC	16,199	$50K	0.0%	N/A	0.112%
2/20/2024	Eventide Asset Management LLC	1,394,336	$3.25M	0.1%	N/A	9.988%
2/15/2024	Parkman Healthcare Partners LLC	696,470	$1.62M	0.2%	N/A	4.990%
5/15/2023	DSC Advisors L.P.	115,000	$0.35M	0.3%	-92.7%	3.523%
5/10/2023	Staley Capital Advisers Inc.	23,472	$72K	0.0%	-62.4%	0.720%
10/7/2022	Mackenzie Financial Corp	134,920	$30K	0.0%	+106.8%	0.233%
4/25/2022	Bailard Inc.	139,381	$91K	0.0%	N/A	0.248%
2/15/2022	DSC Advisors L.P.	2,551,000	$2.60M	2.0%	+131.9%	4.767%
2/14/2022	Perceptive Advisors LLC	2,178,022	$2.22M	0.0%	-6.5%	4.070%
2/14/2022	GSA Capital Partners LLP	217,747	$0.22M	0.0%	+135.7%	0.407%
1/24/2022	SkyOak Wealth LLC	27,200	$28K	0.0%	N/A	0.051%
12/3/2021	Perceptive Advisors LLC	2,330,471	$3.24M	0.0%	-59.6%	4.355%
11/16/2021	Thrivent Financial for Lutherans	71,990	$0.10M	0.0%	+20.2%	0.140%
11/15/2021	683 Capital Management LLC	715,386	$0.99M	0.0%	-2.5%	1.389%
11/15/2021	Healthcare Value Capital LLC	400,000	$0.56M	1.1%	-11.1%	0.777%
11/15/2021	Franklin Resources Inc.	1,921,236	$2.67M	0.0%	+1.1%	3.730%
11/15/2021	GSA Capital Partners LLP	92,402	$0.13M	0.0%	N/A	0.179%
11/12/2021	Renaissance Technologies LLC	1,245,027	$1.73M	0.0%	+300.4%	2.417%
11/5/2021	Staley Capital Advisers Inc.	50,000	$70K	0.0%	+33.3%	0.097%
10/29/2021	Banque Cantonale Vaudoise	80,000	$0.11M	0.0%	-60.0%	0.155%
10/13/2021	Deltec Asset Management LLC	30,000	$42K	0.0%	-92.2%	0.058%
9/24/2021	Thrivent Financial for Lutherans	59,884	$0.21M	0.0%	N/A	0.116%
8/19/2021	Thrivent Financial for Lutherans	59,884	$0.21M	0.0%	N/A	0.116%
8/17/2021	Millennium Management LLC	679,211	$2.38M	0.0%	+2,513.0%	1.322%
8/17/2021	Price T Rowe Associates Inc. MD	40,050	$0.14M	0.0%	+23.5%	0.078%
8/17/2021	683 Capital Management LLC	733,683	$2.58M	0.1%	N/A	1.428%
8/16/2021	LMR Partners LLP	19,758	$69K	0.0%	N/A	0.038%
8/16/2021	Cubist Systematic Strategies LLC	121,419	$0.43M	0.0%	N/A	0.236%
8/16/2021	Perceptive Advisors LLC	5,773,954	$20.27M	0.2%	-14.8%	11.236%
8/16/2021	Charles Schwab Investment Management Inc.	20,154	$71K	0.0%	-79.6%	0.039%
8/16/2021	State Street Corp	534,613	$1.88M	0.0%	-44.3%	1.040%
8/16/2021	Tibra Equities Europe Ltd	91,000	$0.32M	0.1%	N/A	0.177%
8/13/2021	Renaissance Technologies LLC	310,927	$1.09M	0.0%	N/A	0.605%
8/13/2021	Northern Trust Corp	98,524	$0.35M	0.0%	-74.9%	0.192%
8/13/2021	Franklin Resources Inc.	1,900,863	$6.67M	0.0%	+12.5%	3.699%
8/13/2021	AXA S.A.	120,644	$0.42M	0.0%	-86.3%	0.235%
8/13/2021	Geode Capital Management LLC	466,599	$1.64M	0.0%	-36.0%	0.908%
8/13/2021	Vanguard Group Inc.	2,436,432	$8.55M	0.0%	-2.1%	4.741%
8/12/2021	JPMorgan Chase & Co.	11,008	$38K	0.0%	-85.9%	0.021%
8/12/2021	Ergoteles LLC	158,800	$0.56M	0.0%	N/A	0.309%
8/12/2021	Connor Clark & Lunn Investment Management Ltd.	60,186	$0.21M	0.0%	N/A	0.117%
8/11/2021	Bank of New York Mellon Corp	26,626	$94K	0.0%	-81.4%	0.052%
8/11/2021	BlackRock Inc.	1,037,677	$3.64M	0.0%	-71.2%	2.019%
8/11/2021	Deutsche Bank AG	48,234	$0.17M	0.0%	+104.2%	0.094%
8/11/2021	Banque Cantonale Vaudoise	200,000	$0.70M	0.0%	N/A	0.389%
8/10/2021	Principal Financial Group Inc.	11,849	$42K	0.0%	N/A	0.023%
8/9/2021	Staley Capital Advisers Inc.	37,500	$0.13M	0.0%	+50.0%	0.073%
8/6/2021	HighTower Advisors LLC	13,504	$50K	0.0%	-44.3%	0.026%
8/5/2021	Platform Technology Partners	15,832	$56K	0.0%	N/A	0.031%
8/5/2021	Fernwood Investment Management LLC	10,802	$38K	0.0%	-29.4%	0.021%
5/20/2021	Axiom Investment Management LLC	14,297	$0.10M	0.0%	N/A	0.028%
5/19/2021	Virtu Financial LLC	13,598	$93K	0.0%	-79.5%	0.026%
5/19/2021	Squarepoint Ops LLC	17,583	$0.12M	0.0%	-96.8%	0.034%
5/18/2021	Millennium Management LLC	25,994	$0.18M	0.0%	N/A	0.051%
5/18/2021	Highland Capital Management Fund Advisors L.P.	10,051	$69K	0.0%	-75.0%	0.020%
5/18/2021	State of Wisconsin Investment Board	50,898	$0.35M	0.0%	-75.0%	0.099%
5/18/2021	Jane Street Group LLC	16,829	$0.12M	0.0%	N/A	0.033%
5/18/2021	California State Teachers Retirement System	54,938	$0.38M	0.0%	-75.0%	0.107%
5/18/2021	Beacon Pointe Advisors LLC	12,243	$83K	0.0%	-72.9%	0.024%
5/17/2021	Vivo Capital LLC	234,877	$1.61M	0.1%	-75.0%	0.457%
5/17/2021	Schonfeld Strategic Advisors LLC	17,450	$0.12M	0.0%	-76.7%	0.034%
5/17/2021	Perceptive Advisors LLC	6,773,954	$46.37M	0.6%	-70.4%	13.182%
5/17/2021	CSS LLC IL	25,264	$0.17M	0.0%	-78.2%	0.049%
5/17/2021	Price T Rowe Associates Inc. MD	32,441	$0.22M	0.0%	N/A	0.063%
5/17/2021	Ameriprise Financial Inc.	32,078	$0.22M	0.0%	-83.2%	0.062%
5/17/2021	Nuveen Asset Management LLC	146,946	$1.01M	0.0%	-76.2%	0.286%
5/17/2021	Healthcare Value Capital LLC	400,000	$2.74M	6.1%	-80.0%	0.778%
5/17/2021	Goldman Sachs Group Inc.	45,271	$0.31M	0.0%	-74.2%	0.088%
5/14/2021	First Manhattan Co.	5,329	$36K	0.0%	-75.0%	0.010%
5/14/2021	Tekla Capital Management LLC	135,395	$0.93M	0.0%	-75.0%	0.263%
5/14/2021	BDO Wealth Advisors LLC	5,000	$34K	0.0%	-75.0%	0.010%
5/13/2021	Franklin Resources Inc.	1,689,263	$11.56M	0.0%	-75.0%	3.287%
5/13/2021	Axiom Investment Management LLC	14,297	$0.10M	0.0%	N/A	0.028%
5/13/2021	Bank of New York Mellon Corp	142,968	$0.98M	0.0%	-74.0%	0.278%
5/13/2021	Citigroup Inc.	149,164	$1.02M	0.0%	+356.8%	0.290%
5/12/2021	Northern Trust Corp	393,272	$2.69M	0.0%	-74.5%	0.765%
5/12/2021	Geode Capital Management LLC	729,623	$4.99M	0.0%	-68.4%	1.420%
5/12/2021	CM Management LLC	143,750	$0.98M	0.7%	-77.7%	0.280%
5/12/2021	JPMorgan Chase & Co.	77,832	$0.53M	0.0%	-86.8%	0.151%
5/12/2021	UBS Group AG	6,657	$46K	0.0%	-95.5%	0.013%
5/11/2021	New York State Common Retirement Fund	24,349	$0.17M	0.0%	-75.0%	0.047%
5/10/2021	HighTower Advisors LLC	24,228	$0.17M	0.0%	N/A	0.047%
5/10/2021	State Board of Administration of Florida Retirement System	12,564	$86K	0.0%	-75.0%	0.024%
5/7/2021	BlackRock Inc.	3,606,773	$24.69M	0.0%	-69.9%	7.019%
5/7/2021	American International Group Inc.	21,157	$0.15M	0.0%	-74.9%	0.041%

Data available starting January 2016

See Full Table

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions. The company's lead product is VYN201, a locally administered pan- bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor for the treatment of immuno-inflammatory indications. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Today's Range

Now: $1.85

$1.77

$1.97

50 Day Range

MA: $2.68

$1.85

$4.28

52 Week Range

Now: $1.85

$1.57

$4.30

Volume

43,742 shs

Average Volume

81,210 shs

Market Capitalization

$27.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of VYNE Therapeutics?: VYNE Therapeutics' top insider investors include:
Patrick G Lepore (Director)
Mutya Harsch (Insider)
Learn More about top insider investors at VYNE Therapeutics.
Who are the major institutional investors of VYNE Therapeutics?: VYNE Therapeutics' top institutional shareholders include:
Acorn Capital Advisors LLC — 3.10%
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC — 1.67%
Schonfeld Strategic Advisors LLC — 1.20%
Adage Capital Partners GP L.L.C. — 1.04%
Parkman Healthcare Partners LLC — 1.04%
Bridgeway Capital Management LLC — 0.25%
Learn More about top institutional investors of VYNE Therapeutics stock.
Which major investors are selling VYNE Therapeutics stock?: Within the previous quarter, VYNE stock was sold by these institutional investors:
Renaissance Technologies LLC
Parkman Healthcare Partners LLC
Northern Trust Corp
Which major investors are buying VYNE Therapeutics stock?: Within the previous quarter, VYNE stock was bought by institutional investors including:
Acorn Capital Advisors LLC
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC
Adage Capital Partners GP L.L.C.
Bridgeway Capital Management LLC
XTX Topco Ltd
Jane Street Group LLC
Schonfeld Strategic Advisors LLC
During the last year, these company insiders have bought VYNE Therapeutics stock:
Patrick G Lepore (Director)
Mutya Harsch (Insider)
Learn More investors buying VYNE Therapeutics stock.